Atai Beckley N.V.

ATAI

Atai Beckley N.V.

ATAI

Insider Sentiment (TTM):

Last Purchase:2025-08-14Last Sale:2025-03-21Shares Purchased (TTM):8,675,799Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:46,893,825Shares Outstanding:108,800,748Institutional Ownership Pct.:43.10%

Earnings Market Reaction:

Filing Date:2025-11-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	30	62	48	18	30	19	19	45	76	141	186	191
Restricted Cash And Investments Current	0	0	10	10	15	15	5	0	-	-	-	-
Prepaid Expense And Other Assets Current	6	7	8	8	7	5	6	6	7	6	9	14
Notes And Loans Receivable Net Current	-	-	-	0	6	2	1	1	-	9	9	0
Notes Receivable Fair Value Disclosure	10	-	-	-	-	-	-	-	-	-	-	-
Assets Current	131	103	116	80	114	118	118	186	216	243	268	287
Restricted Cash And Investments Noncurrent	-	-	-	-	-	-	10	-	-	-	-	-
Property Plant And Equipment Net	3	3	3	3	1	1	1	1	1	1	1	1
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	0
Operating Lease Right Of Use Asset	3	3	2	1	1	1	1	1	1	1	1	0
Restricted Investments At Fair Value	34	17	23	29	45	61	90	90	72	-	-	0
Other Long Term Investments	54	54	42	42	34	32	33	2	4	4	6	7
Notes Receivable Related Parties Noncurrent	-	-	-	-	-	-	-	-	-	1	1	7
Intangible Assets Net Excluding Goodwill	3	3	3	3	-	-	-	2	-	-	-	-
Goodwill	0	0	0	0	-	-	-	0	-	-	-	-
Notes And Loans Receivable Net Noncurrent	-	-	-	0	0	0	0	0	10	-	-	7
Notes Receivable By Owner To Limited Liability Com…	-	-	-	0	0	0	14	11	2	-	-	0
Other Assets Noncurrent	0	0	1	1	2	2	3	1	3	3	3	3
Assets	240	189	196	159	198	216	269	293	308	254	281	305
Liabilities And Stockhold…
Liabilities Current
Operating Lease Liability Current	-	-	-	-	-	-	-	-	0	0	0	-
Accounts Payable Current	5	4	3	3	5	4	4	5	6	4	5	2
Accrued Liabilities Current	10	15	9	10	12	13	11	15	13	13	14	17
Business Combination Contingent Consideration Liab…	1	0	0	0	0	0	0	0	-	-	-	0
Other Long Term Debt Current	0	0	11	6	-	-	-	0	-	-	-	-
Other Liabilities Current	0	0	2	3	0	1	-	0	1	1	1	0
Liabilities Current	17	26	29	25	20	18	15	20	20	18	20	20
Business Combination Contingent Consideration Liab…	0	0	0	0	1	1	1	1	1	1	1	1
Operating Lease Liability Noncurrent	2	3	3	1	1	1	1	1	1	1	1	0
Long Term Debt	0	0	9	14	20	15	15	15	15	15	15	15
Other Liabilities Noncurrent	3	3	3	3	8	8	8	8	3	3	3	4
Liabilities	80	45	44	43	51	47	46	49	40	38	40	40
Stockholders Equity
Common Stock Value	27	24	22	19	19	19	19	19	19	19	19	19
Additional Paid In Capital	969	895	876	816	808	803	801	795	799	792	783	774
Accumulated Other Comprehensive Income Loss Net Of…	-21	-21	-19	-18	-20	-19	-19	-19	-19	-21	-21	-22
Retained Earnings Accumulated Deficit	-815	-754	-727	-700	-661	-635	-578	-551	-533	-577	-544	-510
Stockholders Equity	160	144	152	117	146	169	223	243	266	213	237	261
Minority Interest	0	0	0	0	1	1	1	1	2	3	4	5
Liabilities And Stockholders Equity	240	189	196	159	198	216	269	293	308	254	281	305
Common Stock Par Or Stated Value Per Share	0.12	0.12	0.11	0.1	0.11	0.11	0.11	0.12	0.12	0.12	0.12	0.12
Common Stock Shares Authorized	375	375	375	375	375	375	375	375	375	375	375	375
Common Stock Shares Issued	120	106	100	84	84	84	83	83	83	83	83	83
Shares Outstanding	120	106	100	84	84	84	83	83	83	83	83	83

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	68.53%	93.71%	191.61%	13.97%	30.42%	45.64%	-0.23%	-10.62%	-13.16%	-	-	-
2024	-32.20%	-38.05%	-32.20%	-2.46%	-4.92%	-11.48%	15.56%	31.11%	14.81%	-11.64%	-4.79%	65.07%
2023	-10.20%	-12.24%	5.10%	-9.94%	-24.56%	-38.01%	-3.59%	30.68%	41.04%	-6.09%	-13.20%	-30.46%
2022	-	-	-	-	-	-	-	-	-	50.40%	52.00%	40.00%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	7.90	4.02	4.07	3.21	5.81	6.68	7.83	9.22	10.96	13.54	13.43	14.43
Quick Ratio	7.54	3.76	3.80	2.90	5.43	6.42	7.44	8.93	10.61	13.19	12.97	13.73
Working Capital	114.12M	77.13M	87.48M	55.17M	94.43M	100.26M	102.49M	165.47M	196.13M	224.84M	247.98M	267.25M
Leverage & Debt
Debt to Equity	0.50	0.31	0.29	0.37	0.35	0.28	0.21	0.20	0.15	0.18	0.17	0.15
Interest Coverage TTM	-49.32	-33.98	-29.66	-32.87	-37.03	-39.86	-42.76	-47.24	-44.82	-64.03	-93.57	-156.87
Debt Ratio	0.33	0.24	0.22	0.27	0.26	0.22	0.17	0.17	0.13	0.15	0.14	0.13
Efficiency & Turnover
Asset Turnover TTM	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.41	-1.21	-1.68	-1.86	-1.59	-0.72	-0.43	-0.51	-0.81	-1.94	-1.97	-2.02
Free Cash Flow Per Share TTM	-0.74	-0.77	-0.88	-1.03	-1.00	-0.99	-1.08	-1.06	-1.20	-1.32	-1.32	-1.35
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	945.86%	962.39%	-	-	-
Operating Profit Margin TTM	-3,457.72%	-4,266.78%	-5,312.72%	-33,341.23%	-32,017.22%	-29,155.82%	-42,000.72%	-39,958.92%	-38,649.25%	-51,861.76%	-53,540.37%	-62,140.34%
Net Profit Margin TTM	-5,087.91%	-5,144.65%	-7,963.29%	-48,463.96%	-38,577.04%	-15,346.03%	-12,442.96%	-12,810.19%	-21,422.09%	-55,454.41%	-56,919.63%	-67,560.94%
Growth Metrics
Net Revenue Growth (1Y)	811.78%	510.85%	572.56%	-1.91%	-1.19%	38.97%	2.59%	34.76%	-98.35%	-98.68%	-98.67%	-
Net Income Growth (1Y)	20.25%	104.78%	330.43%	271.09%	77.93%	-61.54%	-77.57%	-74.45%	-63.64%	-21.78%	-24.91%	-
EPS Growth (1Y)	-11.23%	67.09%	287.99%	268.02%	72.58%	-62.64%	-78.01%	-74.95%	-63.45%	-22.69%	-26.01%	-
Valuation Metrics
P/E TTM	-3.75	-1.81	-0.81	-0.71	-0.73	-1.84	-4.54	-2.78	-1.40	-0.89	-0.92	-1.32
P/B TTM	3.60	1.50	0.79	0.91	0.64	0.63	0.70	0.46	0.38	0.63	0.60	0.79
P/S TTM	190.71	93.22	64.34	345.80	281.45	282.16	565.01	356.62	299.96	492.58	522.19	888.87
Market Cap	575.56M	215.24M	119.86M	106.51M	93.16M	106.66M	156.51M	111.98M	100.49M	133.98M	140.99M	207.11M
Enterprise Value	545.15M	153.30M	70.88M	93.13M	68.53M	87.56M	137.78M	81.99M	38.95M	7.76M	-30.11M	31.20M
Calculated Values
Free Cash Flow TTM	-80.29M	-75.97M	-77.98M	-82.44M	-80.11M	-79.20M	-85.62M	-84.44M	-93.11M	-103.19M	-102.59M	-105.24M
Net Debt	-30.40M	-61.94M	-48.99M	-13.37M	-24.63M	-19.10M	-18.73M	-29.99M	-61.54M	-126.22M	-171.10M	-175.91M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-08-14Purchase

Owner: Apeiron, Investment Group…

Title: -

Shares: 8,675,799

Price/Share: $2.19

Value: $18,999,999.81

Shares Owned: 51,045,214

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-03-24Purchase

Owner: Apeiron, Investment Group…

Title: -

Shares: 1,800,000

Price/Share: $1.40

Value: $2,520,000.00

Shares Owned: 42,369,415

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-03-21Sale

Owner: Rao, Srinivas

Title: See Remarks

Shares: 75,418

Price/Share: $1.35

Value: $101,814.30

Shares Owned: 212,942

Relationship: Officer

Ownership: Direct

2025-03-21Sale

Owner: Short, Glenn Frank

Title: Chief Scientific Officer

Shares: 13,161

Price/Share: $1.35

Value: $17,767.35

Shares Owned: 42,333

Relationship: Officer

Ownership: Direct

2025-03-21Sale

Owner: Kirpekar, Sahil

Title: Chief Business Officer

Shares: 48,563

Price/Share: $1.35

Value: $65,560.05

Shares Owned: 115,636

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-08-14	Apeiron, Investment Group…	Director,TenPercentOwner	-	Indirect	Purchase	8,675,799	2.19	$18,999,999.81	51,045,214	4
2025-03-24	Apeiron, Investment Group…	Director,TenPercentOwner	-	Indirect	Purchase	1,800,000	1.40	$2,520,000.00	42,369,415	4
2025-03-21	Rao, Srinivas	Officer	See Remarks	Direct	Sale	75,418	1.35	$101,814.30	212,942	4
2025-03-21	Short, Glenn Frank	Officer	Chief Scientific Officer	Direct	Sale	13,161	1.35	$17,767.35	42,333	4
2025-03-21	Kirpekar, Sahil	Officer	Chief Business Officer	Direct	Sale	48,563	1.35	$65,560.05	115,636	4
2025-03-21	Johnson, Anne Nagengast	Officer	Chief Financial Officer	Direct	Sale	33,545	1.35	$45,285.75	140,045	4
2025-03-21	Craig, Kevin James	Officer	Chief Medical Officer	Direct	Sale	11,563	1.35	$15,610.05	8,437	4
2025-02-14	Apeiron, Investment Group…	Director,TenPercentOwner	-	Indirect	Purchase	10,835,718	2.10	$22,755,007.80	40,555,215	4
2024-05-16	Brand, Florian	Officer	See Remarks	Direct	Sale	151,303	1.92	$290,501.76	328,697	4
2024-04-02	Kirpekar, Sahil	Officer	Chief Business Officer	Direct	Sale	35,801	1.85	$66,231.85	64,199	4
2024-04-02	Rao, Srinivas	Officer	See Remarks	Direct	Sale	61,640	1.85	$114,034.00	113,360	4
2024-04-02	Johnson, Anne Nagengast	Officer	Chief Financial Officer	Direct	Sale	27,410	1.85	$50,708.50	73,590	4
2023-11-16	Brand, Florian	Officer	See Remarks	Direct	Purchase	20,000	1.16	$23,200.00	130,000	4
2023-09-13	Brand, Florian	Officer	See Remarks	Direct	Purchase	40,000	1.45	$58,000.00	110,000	4
2023-03-29	Angermayer, Christian, Ap…	TenPercentOwner	-	Indirect	Purchase	1,214,297	1.32	$1,602,872.04	32,086,697	4
2023-03-29	Brand, Florian	Officer	See Remarks	Direct	Purchase	70,000	1.48	$103,600.00	70,000	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

43.10%

Inst. Shares: 46,893,825

Shares Outstanding: 108,800,748

2025-09-30

37.72%

Inst. Shares: 41,036,165

Shares Outstanding: 108,800,748

2025-06-30

29.28%

Inst. Shares: 28,774,337

Shares Outstanding: 98,281,850

2025-03-31

24.54%

Inst. Shares: 21,632,261

Shares Outstanding: 88,135,588

2024-12-31

17.40%

Inst. Shares: 13,933,928

Shares Outstanding: 80,079,992

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	46,893,825	108,800,748	43.10%
2025-09-30	41,036,165	108,800,748	37.72%
2025-06-30	28,774,337	98,281,850	29.28%
2025-03-31	21,632,261	88,135,588	24.54%
2024-12-31	13,933,928	80,079,992	17.40%
2024-09-30	11,179,230	80,310,909	13.92%
2024-06-30	11,505,279	80,193,851	14.35%
2024-03-31	11,992,949	79,445,534	15.10%
2023-12-31	12,770,349	79,416,893	16.08%
2023-09-30	13,825,400	77,896,245	17.75%
2023-06-30	14,693,054	77,896,245	18.86%
2023-03-31	15,234,568	77,896,245	19.56%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Atai Beckley N.V. (ATAI) — SEC Financial Statements & Analysis

Atai Beckley N.V. (ATAI) is a pharmaceutical preparations company, incorporated in P7. Atai Beckley N.V. trades on ATAI: Nasdaq as: ATAI. Based on its latest SEC filing (Form 10-Q, period ending 2025-09-30), Atai Beckley N.V. reported a 811.78% year-over-year revenue growth, a Gross Profit Margin of 945.86% (TTM), a Debt-to-Equity ratio of 0.50x, a Price-to-Sales (P/S) ratio of 190.71x (TTM), a Price-to-Book (P/B) ratio of 3.6 (TTM), at a market cap of $575.56M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 811.78%
Gross Profit Margin TTM: 945.86%
Debt To Equity: 0.50x
P/S TTM: 190.71x
P/B TTM: 3.6
Market Cap: $575.56M

Data as of 2025-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Atai Beckley N.V. in?

Atai Beckley N.V. (ATAI) operates in the Pharmaceutical Preparations industry.

What is ATAI's market cap?

Atai Beckley N.V. (ATAI) has a market capitalization of $575.56M as of 2025-09-30.

What exchange does ATAI trade on?

Atai Beckley N.V. (ATAI) trades on the ATAI: Nasdaq.

Where is Atai Beckley N.V. incorporated?

Atai Beckley N.V. is incorporated in Netherlands.

Atai Beckley N.V. (ATAI) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.